MDT

83.98

-0.32%↓

VEEV

228.42

-0.52%↓

105.59

-0.73%↓

WBA

10.92

-0.36%↓

CHE

567.64

-0.14%↓

MDT

83.98

-0.32%↓

VEEV

228.42

-0.52%↓

105.59

-0.73%↓

WBA

10.92

-0.36%↓

CHE

567.64

-0.14%↓

MDT

83.98

-0.32%↓

VEEV

228.42

-0.52%↓

105.59

-0.73%↓

WBA

10.92

-0.36%↓

CHE

567.64

-0.14%↓

MDT

83.98

-0.32%↓

VEEV

228.42

-0.52%↓

105.59

-0.73%↓

WBA

10.92

-0.36%↓

CHE

567.64

-0.14%↓

MDT

83.98

-0.32%↓

VEEV

228.42

-0.52%↓

105.59

-0.73%↓

WBA

10.92

-0.36%↓

CHE

567.64

-0.14%↓

Начало・Списък с акции・LivaNova PLC

LivaNova PLC

Отворен

37.13 -0.48

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

36.61

Максимум

37.89

Ключови измерители
By Trading Economics
Приходи	23M 56M
Продажби	3.7M 322M
P/E Средно за сектора	32.336 56.294
EPS	0.81
Марж на печалбата	17.368
Служители	2,900
EBITDA	11M 85M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+57.66% upside

Дивиденти
By Dow Jones
Следващи печалби	7.05.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-649M 2B
Предишно отваряне	37.61
Предишно затваряне	37.13

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

37.305 / N/A Подкрепа & съпротива

LivaNova PLC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

29.04.2025 г., 23:53 ч. UTC

Горещи акции

Stocks to Watch: Starbucks, Snap, Super Micro Computer, Seagate Technology

29.04.2025 г., 23:06 ч. UTC

Печалби

Prudential PLC 1Q New Business Profit Increases by 12%

29.04.2025 г., 23:00 ч. UTC

Печалби

America Movil's Posts Rise in 1Q Profit, Revenue

30.04.2025 г., 00:00 ч. UTC

Топ новини

Buffett's 'Woodstock for Capitalists' Draws Admirers From Around the Globe -- WSJ

29.04.2025 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Rise as Fears About U.S. Tariffs Ebb -- Market Talk

29.04.2025 г., 23:43 ч. UTC

Пазарно говорене

Gold Consolidates; Signs of Easing in U.S. Tariffs' Impact May Weigh -- Market Talk

29.04.2025 г., 23:41 ч. UTC

Печалби

China Minsheng Banking 1Q Net Interest Income CNY24.87B Vs. CNY24.26B>1988.HK

29.04.2025 г., 23:41 ч. UTC

Печалби

China Minsheng Banking 1Q Operating Income CNY36.81B Vs. CNY34.27B>1988.HK

29.04.2025 г., 23:41 ч. UTC

Печалби

China Minsheng Banking 1Q Net CNY12.74B Vs. Net CNY13.45B >1988.HK

29.04.2025 г., 23:24 ч. UTC

Печалби

China Vanke 1Q Rev CNY37.99B Vs. CNY61.59B >000002.SZ

29.04.2025 г., 23:24 ч. UTC

Печалби

China Vanke: Increase in Investment Losses Also Hurt Results >000002.SZ

29.04.2025 г., 23:24 ч. UTC

Печалби

China Vanke 1Q Loss CNY6.25B Vs. Loss CNY361.97M >000002.SZ

29.04.2025 г., 23:24 ч. UTC

Печалби

China Vanke: Singificant Decline in Property Sales Weighed on Results >000002.SZ

29.04.2025 г., 23:24 ч. UTC

Печалби

China Vanke 1Q Loss Widened Significantly >000002.SZ

29.04.2025 г., 23:15 ч. UTC

Топ новини

UPS to Cut 20,000 Jobs After Amazon Breakup -- 2nd Update

29.04.2025 г., 23:14 ч. UTC

Печалби

China Eastern Airlines 1Q Loss CNY995.0M Vs. Loss CNY803.0M >0670.HK

29.04.2025 г., 23:14 ч. UTC

Печалби

China Eastern Airlines: Increased Competition in the Aviation Market Hurt Results >0670.HK

29.04.2025 г., 23:14 ч. UTC

Печалби

China Eastern Airlines 1Q Rev CNY33.41B Vs. CNY33.19B >0670.HK

29.04.2025 г., 23:14 ч. UTC

Печалби

China Eastern Airlines 1Q Loss Widened >0670.HK

29.04.2025 г., 23:11 ч. UTC

Печалби

China Southern Airlines Swung to Loss in 1Q>1055.HK

29.04.2025 г., 23:11 ч. UTC

Печалби

China Southern Airlines 1Q Rev CNY43.41B Vs. CNY44.60B >1055.HK

29.04.2025 г., 23:11 ч. UTC

Печалби

China Southern Airlines: Shift in Traveler Demographics, Competition From High-Speed Rail Networks Also Hurt Results >1055.HK

29.04.2025 г., 23:11 ч. UTC

Печалби

China Southern Airlines 1Q Loss CNY747.0M Vs. Net CNY756.0M >1055.HK

29.04.2025 г., 23:11 ч. UTC

Печалби

China Southern Airlines: CNY Depreciation, Global Supply Chain Constraints Among Factors Weighing on Results >1055.HK

29.04.2025 г., 23:07 ч. UTC

Печалби

Air China 1Q Rev CNY40.02B Vs. CNY40.07B >0753.HK

29.04.2025 г., 23:07 ч. UTC

Печалби

Air China 1Q Losses Widened>0753.HK

29.04.2025 г., 23:07 ч. UTC

Печалби

Air China 1Q Loss CNY2.04B Vs. Loss CNY1.67B >0753.HK

29.04.2025 г., 23:02 ч. UTC

Печалби

COSCO SHIPPING Energy Transportation: Weaker Earnings In International Oil Tanker Fleet Business Weighed on Results>1138.HK

29.04.2025 г., 23:02 ч. UTC

Печалби

COSCO SHIPPING Energy Transportation 1Q Net CNY707.70M Vs. Net CNY1.24B >1138.HK

29.04.2025 г., 23:02 ч. UTC

Печалби

COSCO SHIPPING Energy Transportation 1Q Rev CNY5.75B Vs. CNY5.84B >1138.HK

Сравнение с други в отрасъла

Ценова промяна

LivaNova PLC Прогноза

Ценова цел

By TipRanks

57.66% нагоре

12-месечна прогноза

Среден 59.14 USD 57.66%

Висок 74 USD

Нисък 50 USD

Според 8 анализатори от Wall Street, предложили 12-месечна ценова цел за LivaNova PLC през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

8 ratings

Купи

Задържане

Продай

Според 8 анализатори, дали борсови рейтинги на LivaNova PLC през последните 3 месеца.

Техническа оценка

By Trading Central

37.305 / N/AПодкрепа & съпротива

Recent bullish events outweigh bearish events.

All events are bearish.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно LivaNova PLC

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.